Pfizer, BioNTech sign $1.9bn deal for additional doses of BNT162b2 with US
Pfizer and BioNTech have signed an agreement worth $1.95bn with the US government for the supply of an additional 100 million doses of their Covid-19 vaccine BNT162b2. The
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XPfizer and BioNTech have signed an agreement worth $1.95bn with the US government for the supply of an additional 100 million doses of their Covid-19 vaccine BNT162b2. The
AdaptHealth has agreed to acquire AeroCare, a US-based technology-enabled respiratory and home medical equipment (HME) provider, in a cash-cum-stock deal worth around $2bn. As per the terms of
Danish healthcare firm Novo Nordisk has agreed to acquire Emisphere Technologies, a US-based drug delivery company, for $1.8bn. Emisphere Technologies uses its proprietary technologies, which include Eligen SNAC
Johnson & Johnson (J&J) has temporarily paused further dosing in all its Covid-19 vaccine candidate clinical trials, following an unexplained illness in one of the participants. The Covid-19
Siemens Healthineers has agreed to acquire US-based Varian Medical Systems, an oncology-focused medical devices and software manufacturer, for about $16.4bn in an all-cash deal The German medical technology
Novartis said that it will initiate a phase 3 trial in collaboration with Incyte to assess the use of the cancer drug Jakavi (ruxolitinib) in severe COVID-19 patients.
Merck has been granted approval for its Ervebo vaccine from the US Food and Drug Administration for the prevention of Ebola virus disease (EVD) caused by Zaire ebolavirus.
Novartis has officially inaugurated a new $90m cell and gene therapies manufacturing facility in Stein in the Swiss canton Aargau. Apart from housing manufacturing areas for chimeric antigen
Incyte has secured priority review from the US Food and Drug Administration (FDA) for its new drug application (NDA) for pemigatinib as a new treatment for cholangiocarcinoma. The
EOS imaging is set to launch EOSedge, the company’s new generation imaging system, across Europe, Canada and Australia, having secured regulatory approvals in the respective regions. The French